Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (31-40 of 785) with videos related to

Pageof 79
Sort By:
Journal of the American College of Cardiology|June 2, 2018
Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REALMichael E Farkouh, Subodh Verma
Cell Metabolism|August 11, 2016
Empagliflozin's Fuel Hypothesis: Not so SoonGary D Lopaschuk, Subodh Verma
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 19, 2026
Heart Transplantation in the GLP-1 Era: Time to Catch Up?. Invited Commentary for "The association between glucagon-like peptide 1 receptor agonist therapy and outcomes after heart transplant"Nitish K Dhingra, Subodh Verma
Diabetes Care|September 19, 2025
GLP-1 Receptor Agonists Help LegsRonald M Goldenberg, Subodh Verma
Nature Clinical Practice. Cardiovascular Medicine|March 1, 2006
Does cannabis hold the key to treating cardiometabolic disease?Paul E Szmitko, Subodh Verma
The New England Journal of Medicine|August 19, 2005
Nitric oxide-eluting polyurethanes--vascular grafts of the future?Subodh Verma, Philip A Marsden
Journal of the American College of Cardiology|October 15, 2025
Parsing the Adipokine Axis in HFpEFSubodh Verma, Deepak L Bhatt
The New England Journal of Medicine|March 30, 2007
Idiopathic pulmonary fibrosis--new insightsSubodh Verma, Arthur S Slutsky
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2005
Antiatherogenic potential of red wine: clinician updatePaul E Szmitko, Subodh Verma
Hypertension (Dallas, Tex. : 1979)|July 23, 2008
Aliskiren improves nitric oxide bioavailability and limits atherosclerosisSubodh Verma, Milan K Gupta
Pageof 79

Showing results (31-40 of 785) with videos related to

Sort By:
Pageof 79
Journal of the American College of Cardiology|June 2, 2018
Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REALMichael E Farkouh, Subodh Verma
Cell Metabolism|August 11, 2016
Empagliflozin's Fuel Hypothesis: Not so SoonGary D Lopaschuk, Subodh Verma
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 19, 2026
Heart Transplantation in the GLP-1 Era: Time to Catch Up?. Invited Commentary for "The association between glucagon-like peptide 1 receptor agonist therapy and outcomes after heart transplant"Nitish K Dhingra, Subodh Verma
Diabetes Care|September 19, 2025
GLP-1 Receptor Agonists Help LegsRonald M Goldenberg, Subodh Verma
Nature Clinical Practice. Cardiovascular Medicine|March 1, 2006
Does cannabis hold the key to treating cardiometabolic disease?Paul E Szmitko, Subodh Verma
The New England Journal of Medicine|August 19, 2005
Nitric oxide-eluting polyurethanes--vascular grafts of the future?Subodh Verma, Philip A Marsden
Journal of the American College of Cardiology|October 15, 2025
Parsing the Adipokine Axis in HFpEFSubodh Verma, Deepak L Bhatt
The New England Journal of Medicine|March 30, 2007
Idiopathic pulmonary fibrosis--new insightsSubodh Verma, Arthur S Slutsky
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2005
Antiatherogenic potential of red wine: clinician updatePaul E Szmitko, Subodh Verma
Hypertension (Dallas, Tex. : 1979)|July 23, 2008
Aliskiren improves nitric oxide bioavailability and limits atherosclerosisSubodh Verma, Milan K Gupta
Pageof 79